Return On Equity of Neuphoria Therapeutics Inc. from 30 Jun 2024 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neuphoria Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2024 to 31 Dec 2025.
  • Neuphoria Therapeutics Inc. Return On Equity for the quarter ending 31 Dec 2025 was -26%, a 47% increase year-over-year.
  • Neuphoria Therapeutics Inc. annual Return On Equity for 2025 was -2.1%, a 98% increase from 2024.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Neuphoria Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -26% +23% +47% 01 Oct 2025 31 Dec 2025
Q3 2025 -53% +6.8% +11% 01 Jul 2025 30 Sep 2025
Q2 2025 -2.1% +84% +98% 01 Apr 2025 30 Jun 2025
Q1 2025 31% 01 Jan 2025 31 Mar 2025
Q4 2024 -50% 01 Oct 2024 31 Dec 2024
Q3 2024 -60% 01 Jul 2024 30 Sep 2024
Q2 2024 -86% 01 Apr 2024 30 Jun 2024

Neuphoria Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -2.1% +84% +98% 01 Jul 2024 30 Jun 2025
2024 -86% 01 Jul 2023 30 Jun 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.